
FTC’s Arise Case Gives Consumer Advocates a Pick-Me-Up
Some *brighter* news after the Loper Bright SCOTUS decision.
In January 2018, a class-action lawsuit was filed against Enzymatic Therapy for allegedly deceptively advertising that Ultra Liver Cleanse is able to “Remove Toxins” and cleanse and rejuvenate the liver when, according to plaintiffs, the product cannot detoxify, cleanse, or rejuvenate the liver. Plaintiffs also claim that the company misleads consumers by communicating that the product has “drug-like effects” when it is not an FDA approved drug. (Jocelyn et al v. Enzymatic Therapy, LLC, Case No. 18-cv-564, E.D.N.Y.)
Some *brighter* news after the Loper Bright SCOTUS decision.
TINA.org takes a closer look at the fine print behind a 180-night trial.
Lawsuit accuses mega-retailer of misleading consumers looking to buy American-made.
What you see may NOT be what you get.
TINA.org takes a closer look at this MLM offering “braille for your brain.”